Supervisory Physician (Branch Chief)

National Institutes of Health; Rockville (MD); On-site; USD 150,000 - 190,000; Full time

Job summary

The National Institutes of Health is seeking a Supervisory Physician (GP-602-15) to lead the Immuno-Oncology Branch within the Developmental Therapeutics Program of the DCTD. This full-time federal role directs branch activities and coordinates translational immunotherapy research to advance cancer treatment development.

The ideal candidate will hold an MD with immunology/oncology training, possess clinical trials experience, and provide leadership across cross-functional teams. U.S.

Qualifications

• MD with clinical and translational immunology/oncology background.
• Experience leading multi-disciplinary teams in immunotherapy.
• Familiarity with clinical trials and regulatory processes.

Responsibilities

• Direct the Immuno-Oncology Branch activities and strategy.
• Coordinate preclinical and early clinical development of immuno-oncology products.
• Serve as senior advisor to Division and Institute leadership on program priorities.

Skills

Medical degree

Immunotherapy

Oncology

Hematology

Clinical trials

Pharmacology

Education

MD/DO

Job description

The National Cancer Institute (NCI) is seeking candidates with a medical degree and experience in cancer immunotherapy for the position of Supervisory Physician (GP-602-15), Branch Chief of the Immuno-Oncology Branch (IOB), Developmental Therapeutics Program (DTP), Division of Cancer Treatment and Diagnosis (DCTD).

The candidate will serve as a Supervisory Physician/Branch Chief directing the activities of the IOB (https://dtp.cancer.gov/organization/iob/default.htm) and will collaborate with investigators of the DTP (https://dtp.cancer.gov/). The candidate will manage and coordinate all functions of the branch including planning, designing and executing preclinical research and clinical development of immunotherapy agents through a cross-functional collaboration within DTP and DCTD. As a senior advisor to the Division Director and Institute Director, the candidate will set priorities for federal investment in the development of new methods, technologies, and treatment paradigms that integrate immunomodulation strategies into clinical studies. The candidate is expected to manage and coordinate a system of grants and contracts to discover, investigate, develop and bring to initial clinical trials novel immuno-oncology products.

This is a full-time government position. Compensation for this position will be commensurate with the individual’s qualifications and experience as permitted within Federal government appointments. Individuals who apply must be U.S. citizens. The ideal candidate should have a clinical background and training in immunology, medical oncology, hematology, pharmacology, clinical trials, and the development of investigational anti-cancer drugs.

DHHS, NIH and NCI are Equal Opportunity Employers.

The National Cancer Institute (NCI) is seeking candidates with a medical degree and experience in cancer immunotherapy for the position of Supervisory Physician (GP-602-15), Branch Chief of the Immuno-Oncology Branch (IOB), Developmental Therapeutics Program (DTP), Division of Cancer Treatment and Diagnosis (DCTD).

The ideal candidate should have a clinical background and training in immunology, medical oncology, hematology, pharmacology, clinical trials, and the development of investigational anti-cancer drugs.